Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Water | HCID 962 | — |
| Reactant | Lansoprazole | HCID 3883 | — |
| Reactant | Sodium hydride | HCID 24758 | — |
| Reactant | HCID 131724895 | HCID 131724895 | — |
| Solvent | Dichloromethane | HCID 6344 | — |
| Product | HCID 20786373 | HCID 20786373 | 80% |
Reaction Steps
To a heterogeneous mixture of 2-[3-methyl-4-(2,2,2-trifluoroethoxy)pyridin-2-ylmethanesulfinyl]-1H-benzimidazole (500 mg, 1.36 mmol) in CH2Cl2 (10 mL) was added NaH (40 mg, 1.65 mmol) at room temperature resulting in a clear solution. To this clear mixture was added 4-(4-chlorosulfonyl-3-Isopropylphenoxyactamido)-butyric acid 2-(3-nitrobenzenesulfonyl)ethyl ester (Intermediate 26, 1.0 g, 1.70 mmol, 1.25 eq) in CH2Cl2 (5 mL) at room temperature, and then the mixture was stirred for 2 h. Thereafter water was added, the mixture was extracted with CH2Cl2, the organic layers were dried and concentrated under reduced pressure. The residual oil was purified by column chromatography (CH2Cl2 to 3% MeOH in CH2Cl2) to yield Intermediate 27 (1.0 g, 80%) as an off-white foam.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06897227B2 |
|---|
| Source dataset | uspto-grants-2005_05 |
|---|
| ORD ID | ord-c0a6154332c34d42b484c7e05d40dee7 |
|---|
| Source note | uspto-grants-2005_05 |
|---|